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ABSTRACT
Facile and non-radioactive methods are desired for the sensitive detection and quantification of 
various proteins.  Herein we describe a novel chemiluminescence (CL)-detection method of
particular proteins based on direct binding of a dextran-luminol-biotin (DLB) CL polymer to the 
proteins on a poly(vinylidene difluoride) membrane. Among 32 kinds of the proteins screened, 
several proteins such as drug-metabolizing enzymes, cytochrome p450 (CYP)1A2, CYP2E1, and 
CYP3A4 had the ability to bind directly to the DLB polymer. The binding site in the polymer was 
owing to the framework of the modified dextran, which underwent oxidation and reduction 
procedures. This interaction might be the comprehensive effect of both electrostatic interaction 
and steric complementarities. CL intensity of the proteins detected by the polymer could be further 
enlarged by the mediation of avidin. The proposed CL-imaging method possesses potential as a 
rapid, facile, inexpensive and selective detection of the proteins.
Keywords: Protein detection, Microchip, Chemiluminescence, Luminol-containing 
macromolecule
1. Introduction
Enzyme-linked immunosorbent assay (ELISA) on 96-wells plastic plate or membrane matrix 
has been widely used in immunoassay with respect to its specificity and sensitivity. Antibody is 
indispensable in ELISA; it is routinely utilized as an analytical reagent for specific recognition and 
binding with an antigen. However, the preparation of a specific antibody to an antigen is 
expensive, time consuming and laborious, and the antibodies are sensitive to temperature because 
of irreversible denaturation. Artificial antibody-like receptors, such as aptamer and molecular 
imprinting polymer (MIP) could be the solution to such problems. Aptamer is a short DNA or 
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RNA oligonucleotide that provides specific binding to a target protein. Fifteen years since their 
discovery, however, aptamers have been obtained only for limited number of proteins because the 
production of the aptamers is difficult [1, 2]. MIPs are the synthetic compounds that might be 
substituted for antibodies in immunoassay; however, the hydrophobic nature and highly 
cross-linked structure of the polymer limit the access of the large protein molecules to the binding 
sites of MIPs [3-5]. 
The possibility of use of peroxidase or metal enzymes has been recently reported for the 
sensitive chemiluminescence (CL) detection of particular proteins in the ELISA system.  It 
utilizes the fact that the native enzymes such as horse radish peroxidase could catalyze the CL 
reaction between luminol and hydrogen peroxide [6, 7]. In this technique, for example, the 
electrophoresis should be conducted with the usage of non-denatured gel and running at low 
temperature to keep the proteins active; otherwise CL signal cannot be seen.  CL-imaging 
methods offer many advantages for high-throughput evaluation, high sensitivity, simple 
instrumentation, and exclusion of the usage of radioisotopes [8, 9]. We reported a CL 
immunoassay for the sensitive detection of a CYP3A4 protein utilizing two antibodies and a 
dextran-luminol-biotin (DLB) polymer [10]. However, our recent experiments have indicated that 
the DLB polymer directly bound to some proteins on a membrane in the absence of blocking 
agents of the framework of the DLB polymer and dextran. 
In this study, therefore we developed a novel CL-imaging method for particular proteins such 
as CYP proteins on a PVDF membrane (Fig. 1).  The advantage of this method is to permit facile, 
rapid, inexpensive and sensitive detection for those proteins on a solid-phase membrane, because 
the DLB polymer as a signal probe indicated the possibility of the direct binding to the target
proteins.  Many proteins exist in blood plasma, such as complement proteins, proteins for blood 
coagulation, adhesion proteins, lipoproteins, protease inhibitors, immunoglobulin, hormones, 
enzymes, disease-related markers, and so on [11]. We screened 32 kinds of commercially available
proteins to be detected by the DLB polymer. Among of them, lysozyme, fibroblast growth factor 5
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(FGF5), cytochrome c, β-nerve growth factor (β-NGF), CYP1A2, CYP2E1, CYP3A4, prolactin
and concanavalin A exhibited relatively strong interactions with the polymer. Furthermore, several 
experiments were conducted to clarify the mechanism of the interaction between the DLB polymer 
and the proteins.
Fig. 1.  CL detection of a protein on a PVDF membrane by the DLB polymer.
2. Experimental
2.1. Reagents and chemicals
Dextran T500 (average MW 5×105 Da) was purchased from Pharmacia Fine Chemicals 
(Sweden). Sodium periodate and avidin were purchased from Wako (Japan). 6-Hydrazidohexyl-
D-biotinamide was purchased from Dojindo (Japan). Luminol and sodium borohydride were 
purchased from Nacalai Tesque (Japan) and used without further purification. Nylon membranes 
and poly(vinylidene difluoride) (PVDF) membranes (0.45 μm pore size) were supplied by
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Millipore (Billerica, MA, USA). Tetra-n-butylammonium hydroxide (TBA) was supplied by 
Sigma-Aldorich (St. Louis, MO, USA).  Adrenocorticotropin hormone (40 residues, human) and 
a peptide fragment (21 residues) of CYP3A4 (human) were purchased from AnaSpec (San Jose, 
CA, USA). Growth hormone (human recombinant) and parathyroid hormone (human 
recombinant) were purchased from Atgen (Korea). Mouse β-nerve growth factor (β-NGF) was 
supplied by Austral Biologicals (San Ramon, CA, USA). A peptide fragment (12 residues) of 
CYP1A2 (human) was supplied by Biomol (USA). Ceruloplasm (human plasma), concanavalin A 
(canavalia ensiformis), cytochrome c (equine heart), fibrinogen (human plasma), 
follicle-stimulating hormone (human pituitary), peanut lectin (arachis hypogaea), luteinizing 
hormone (human pituitary), serum amyloid A (human serum), superoxide dismutase (human 
recombinant), thrombin (bovine), thyroglobulin (human thyroid), transferring, β2-microglobulin 
(human), and haptoglobin were purchased from Calbiochem (Germany). Bovine serum albumin 
(BSA) was purchased from Nacalai Tesque (Japan).  Hemoglobin (human) was purchased from 
Nutritional Biochemicals (USA). CYP1A2 (human recombinant), CYP2E1 (human recombinant), 
CYP3A4 (human recombinant), monoclonal anti-CYP1A2 antibody (mouse anti-human), and 
polyclonal anti-CYP1A2 antibody (rabbit anti-human) were supplied by Oxford Biochemical 
Research (USA). Fibroblast growth factor 5 (FGF5, human recombinant) and prolactin (mouse 
recombinant) were supplied by R&D Systems (USA). Bovine serum albumin (BSA), lysozyme 
(chicken egg white), myoglobin (equine skeletal muscle), α-amylase (aspergillus oryae), and 
β-lactoglobulin (bovine milk) were purchased from Sigma (St. Louis, MO, USA). 
2.2. Synthesis of a DLB polymer and its related compounds (Fig. 2)
Dextran T500 (400 mg) with ca. 500 kDa in average molecular weight was dissolved in water 
(40 mL) followed by precipitating with methanol. The precipitate was filtered, re-dissolved in 
water (60 mL), and then sodium periodate (317 mg) was added. The reaction mixture was stirred 
at room temperature until the 310 nm UV-absorption band corresponding to sodium periodate 
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disappeared. Then, the reaction mixture was poured into methanol (300 mL), the precipitate of 
partially oxidized dextran (ox-Dex) was filtered off and used in the next step. 
To the oxidized dextran was added dimethyl sulfoxide (DMSO) (40-80 mL) and the mixture 
heated at 100 ℃ to dissolve the oxidized dextran completely. 6-Hydrazidohexyl-D-biotinamide 
(30 mg) was then added to the solution and allowed to stir at room temperature for 3 h. Glacial 
acetic acid (16 mL) and luminol (240 mg) were subsequently added into the reaction mixture and 
left stirring at 60 ℃ overnight. The mixture was poured into methanol (400 mL). Methanol was 
removed from the precipitate by careful decantation, and then another 500 mL of methanol was 
added to the precipitate. After stirring for 30 min, a yellowish powder (DLB polymer) of the 
conjugates was collected by filtration. In the case of the synthesis of the dextran-based compound
containing only luminol (DL), the addition of 6-hydrazidohexyl-D-biotinamide was omitted.
The modified dextran polymer was dissolved in ethyleneglycol (20-60 mL). Excess of 
sodium borohydride (870 mg) was added into the ice-cooled reaction mixture and the mixture was 
left stirring at room temperature for 4 h. Then reaction was continued at 4 ℃ overnight without 
stirring. The desired polymer was reprecipitated by acetone (200 mL), washed three times with 
methanol (300 mL) to remove the unreacted biotin and luminol. The precipitate was then dried in 
vacuo overnight. Three dextran-related compounds were obtained: oxidized and reduced dextran 
(ox-red-Dex) as a white powder (150-200 mg), DL as a pale yellow powder (250-300 mg) and 
DLB polymer as a pale yellow powder (150-200 mg).
2.3. CL detection of DLB polymer on a nylon membrane
Aqueous solution of DLB polymer was spotted on a nylon membrane and dried in vacuo for 10 
min. The membrane was then washed with methanol (2.0 mL) at 37 ℃ for 5 min, and dried again 
in vacuo for 10 min. The membrane was immersed for 10 s in a mixture consisting of 700 μL of 
acetonitrile, 300 μL of 0.5 M TBA and 50 μL of 30 % hydrogen peroxide for the CL reaction. The 
CL-imaging detection was conducted by a CCD camera (Light capture AE-6971/2 device, ATTO, 
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Japan) for 2.0 min of exposure time.
2.4. Binding constant of DLB polymer to avidin
A PVDF membrane was dotted with 3.0 μL of 100 % ethanol followed by spotting of avidin 
(0.5 nM) in water. The membrane was dried in vacuo at 37 ℃ for 10 min. The PVDF membrane 
was incubated with different concentrations of DLB polymer (0.05-0.15 mg mL-1) in 2.0 mL of 25 
mM Tris buffer (pH 7.2) at 37 ℃ for 30 min. The membrane was washed twice at 37 ℃ with
4.0 mL of 10 mM phosphate buffer saline (PBS) containing 0.15 % (w/v) Triton X-100. After the 
consecutive washing of the membrane with 2.0 mL of 75 % (v/v) methanol, the membrane was 
dried in vacuo at 37 ℃ for 10 min. The CL reaction and imaging detection were performed as 
described above. Using Scatchard plot method, the binding constant K of the polymer to avidin 
and the binding molar ratio of avidin to the polymer was calculated.
2.5. Detection of proteins on a PVDF membrane by DLB polymer 
A PVDF membrane was spotted by ethanol (3.0 μL) followed by spotting of various proteins in 
25 mM Tris buffer (pH 7.2). The membrane was dried in vacuo at 37 ℃ for 30 min. The 
membrane was blocked with 3.0 mL of 3 % BSA in 10 mM PBS (pH 7.2), followed by washing 
with 3.0 mL of the PBS. The membrane was incubated in a mixture (2.0 mL) of 2.0 mg DLB 
polymer and 4.0 mg BSA in 25 mM Tris buffer (pH 7.2) at 37 ℃ for 30 min. After the reaction, 
the membrane was washed three times with 5.0 mL of 10 mM PBS containing 1 % Triton X-100, 
followed by washing the membrane with 2.0 mL of 75 % methanol. The membrane was dried in 
vacuo at 37 ℃ for 20 min. The CL reaction and imaging detection were performed as described 
above.
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Prior to the investigation of the direct binding of our DLB polymer to proteins, we 
successively synthesized a series of dextran-related compounds (Fig. 2). The synthetic route to the 
DLB polymer was consisted of 4 steps: partial oxidation of dextran for oxidized dextran (ox-Dex), 
coupling between ox-Dex and luminol for ox-Dex containing luminol (DL), biotinylation of DL 
without reduction for ox-Dex containing luminol and biotin (pre-DLB polymer), and reduction of 
pre-DLB polymer for the DLB polymer. In order to evaluate the protein-binding mechanism of the 
DLB polymer, ox-red-Dex was synthesized by reduction of ox-Dex without luminol and biotin.
Fig. 2. Synthetic pathway of dextran-based polymers.
According to the elemental analysis data, the atomic composition of the synthesized DLB
polymer and its molecular weight can be deduced. The atomic composition of the synthesized 
DLB polymer was 43 % C, 5.8 % H, 4.4 % N, and 0.17 % S, and its molecular weight was found 
to be approximately 6.3 x 105 Da. These data indicate that this polymer contained approximately 
560 and 34 molecules of luminol and biotin, respectively in a dextranT500 molecule (3100 
glucose units).  The aqueous solution of the DLB probe gave approximately 300 times higher CL 
intensity at the same amount (1.0 fmol) of free luminol.  It was found that the increased 
3. Results and discussion
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introduction of luminol gives more intense CL for the probe. 
The CL intensity from the DLB polymer was measured by using different amounts of the 
polymer immobilized on a nylon membrane. The DLB polymer could be visualized by means of 
CL detection. The CL intensity was proportional to the amount of the polymer [y = 0.1583x-0.243, 
r2=0.9965; where y = CL intensity (×106), x = amount of the DLB polymer (ng) and r2 = 
correlation coefficient]. Therefore, a large number of luminol molecules were chemically 
introduced into the polymer and the bound luminol did not lose from the polymer during the assay 
treatment.  Next we investigated the binding ability of the polymer to avidin. It was shown that 
the CL intensity increased with the increased amounts of the polymer. The result indicates that 
biotin moieties in the polymer can bind to avidin. By using Scatchard plot method, the binding 
constant and the binding molar ratio of avidin to DLB polymer were about 5.1×106 M-1 and 60, 
respectively.
The DLB polymer was originally used for the detection of CYP3A4 by binding to 
biotin-containing anti IgG antibody (second antibody) that bound to anti CYP3A4 antibody (first 
antibody) binding to CYP3A4 in immunoassay. When CYP3A4 blotted on a PVDF membrane 
was treated with a mixture of streptavidin, BSA, dextran, ox-red-Dex, the antibodies and the DLB 
polymer, the detection of CYP3A4 could be achieved in the presence of the antibodies (Fig. 3a). 
On the other hand, negligible light was emitted from the protein in the absence of the antibodies 
(Fig. 3b). Although the polymer could be applicable to immunoassay for the sensitive and specific 
detection of a target protein [10], in the absence of blocking substances such as ox-red-Dex and 
dextran, CL emission from CYP3A4 was observed when the membrane was incubated with a 
mixture of the DLB polymer and BSA (Fig. 3c). This result indicated that the DLB polymer has a 
binding site in the molecule.
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Fig. 3.  CL detections of CYP3A4 by immunoassay using anti CYP3A4 antibody, 
biotin-containing anti IgG antibody, and by direct binding of DLB polymer. CYP3A4 (200 ng) 
spotted on a PVDF membrane was incubated at 37 ℃ for 2 h (a) with the first and second 
antibodies, or (b) without the antibodies in 10 mM PBS for control. After washing, the protein was 
detected by CL reaction after the incubation at 37 ℃ for 30 min with a mixture [DLB polymer (4 
mg), streptavidin (4 mg), BSA (6mg), dextran (6 mg) and ox-red-Dex (20 mg) in 2 mL of 10 mM 
PBS] for immunoassay, and (c) for the direct binding of DLB polymer, the membrane was 
incubated with a mixture [DLB polymer (4 mg) and BSA (6 mg) in 2 mL of 10 mM PBS], and 
after washing, the protein was detected by CL reaction.
The above findings encouraged us to apply the DLB polymer to detect directly various 
proteins on a PVDF membrane, which included CYP proteins, carbohydrate-binding proteins, 
hormones, and plasma proteins (Table 1). The data indicated that CYP1A2 had the highest affinity 
to the polymer. CYP2E1, CYP3A4, lysozyme, FGF5, cytochrome c, β-NGF, and prolactin showed 
the strong CL. Hemoglobin, serum amyloid A and concanavalin A exhibited moderate binding 
affinity, while no signal was observed with the other proteins and peptides. Therefore, these 
bindings of the polymer to the proteins are not due to the molecular size of the proteins. It seems 
that the polymer might bind to particular proteins with relatively high isoelectronic point (pI), 
since there were several proteins with high pI values showing no affinity to the polymer, and 
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concanavalin A even with a low pI value of 5 slightly bound to the polymer. No specific reason of 
the preference of the polymer to proteins can be clarified at this stage. However, interesting results 
were obtained from two shorter fragments of CYP1A2 (12 residues) and CYP3A4 (21 residues). 
No CL signals from these fragments were observed, even though the fragments have higher pI 
values. The results indicated that a specific region of the polymer participates in the protein
binding.
It should be noted that the DLB polymer did not bind to the immunoglobulin proteins such as
monoclonal and polyclonal anti-CYP1A2 antibodies, as shown in Table 1. By utilizing this 
characteristic, the development of a new detection method specific for the CYP proteins will be 
possible, in which several CYP proteins are individually recognized and captured by each
anti-CYP antibody immobilized separately on a solid-phase membrane, following the direct 
detection of the CYP proteins on the membrane by the DLB polymer.
Table 1 The list of the proteins used in this study and their corresponding CL intensities.
Protein (100 ng)
MW 
(×103 Dalton ) pI CL intensity %
c
Lysozyme 14 a 11.0 a 30
Fragment (12 residues) of CYP1A2 1.3 10.0 b 0
Fragment (21 residues) of CYP3A4 2.6 9.7 b 0
FGF5 27 9.4 b 88
Cytochrome c 13 9.4 a 17
β-NGF 27 a 9.3 a 35
CYP1A2 58 9.2 b 100
Luteinizing hormone 29 8.8 a 0
CYP2E1 53 8.3 b 57
CYP3A4 66 8.3 b 23
Adrenocorticotropin hormone (40 residues) 4.5 8.1 b 0
Parathyroid hormone 9.6 8.1 a 0
Myoglobin 18 a 8.1 a 0
Hemoglobin 65 a 6.9 a 7
Monoclonal anti-CYP1A2 antibody 150 a 6.5 a 0
Peanut lectin 110 6.5 a 0
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Prolactin 23 6.1 a 37
Serum amyloid A 12 5.9 b 8
Fibrinogen 341 5.6 a 0
Follicle stimulating hormone 36 5.6 a 0
Polyclonal anti-CYP1A2 antibody 150 a 5.5 a 0
α-Amylase 45 a 5.5 a 0
Thrombin 34 5.5 a 0
β2-Microglobulin 12 5.5
a 0
Transferrin 80 5.3 a 0
β-Lactoglobulin 18 a 5.1 a 0
Concanavalin A 104 5.0 a 13
Growth hormone 20 5.0 a 0
BSA 66 4.8 a 0
Superoxide dismutase 32 4.8 a 0
Thyroglobulin 660 4.5 a 0
Ceruloplasm 134 4.4 a 0
Haptoglobin 86 4.2 a 0 
a MW and pI were obtained from a laboratory book.  b pI was calculated from the amino acid 
sequence by the computer software on internet.  Other MW and pI that do not labeled were 
obtained from the product description of the company.  c CL intensity obtained from CYP1A2 
was taken as a reference (100%). 
We investigated the interaction between cytochrome c (cyt c) and the DLB polymer by using 
gel filtration liquid chromatography (GFLC). Cyt c has its maximum absorption at 408 nm, while 
the DLB polymer has no absorption at 408 nm (Fig. 4a and 4b). On the other hand, the DLB 
polymer showed two fluorescence (FL) peaks at the retention times of 13.5 min and 20.5 min. 
These FL peaks were identified as the luminol moiety in the macromolecular polymer (13.5 min) 
and free luminol at 20.5 min. However, the small amount of free luminol (approximately 1%, 
w/w) did not interfere with the detection of a target protein on a membrane, because it could be 
sufficiently removed from the membrane by washing with PBS containing 1% Triton X-100 and
75% methanol.
When the DLB polymer was mixed with cyt c before injection to GFLC, a new broad peak was 
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detected at the retention time of 12.5 min with both the detections of absorbance at 408 nm and FL 
(Fig. 4c), indicating the formation of a complex between cyt c and the DLB polymer. In order to 
confirm the binding site of the DLB polymer to the protein, we synthesized two compounds 
similar to the DLB polymer; one was DL that does not contain biotin, and the other one was 
ox-red-Dex in which the dextran was oxidized and reduced without biotin and luminol. These 
frameworks of the DLB polymer were used to evaluate their binding abilities to cyt c. Figure 4d 
shows that DL could bind to cyt c, indicating that the biotin moiety in the polymer was not the 
binding site for the protein. From Figure 4e, it is clear that ox-red-Dex had the ability to bind to 
cyt c, suggesting that the luminol moiety in the polymer did not bind to the protein. As shown in 
Fig. 4f, the pristine dextran did not bind to the protein. These results lead to the conclusion that the 
framework produced by oxidization and reduction of dextran has the ability to interact with the 
protein.
Fig. 4. GFLC identification of the interaction between the DLB polymer and cytochrome c. 
Samples: (a) 1 mg mL-1 cytochrome c (cyt c); (b) 1 mg mL-1 DLB polymer (DLB); (c) a mixture 
of 1 mg mL-1 DLB and 1 mg mL-1 cyt c at 37 ℃ for 1 h; (d) a mixture of 1 mg mL-1 DL and 1 mg
mL-1 cyt c at 37 ℃ for 1h; (e) a mixture of 1 mg mL-1 ox-red-Dex and 1 mg mL-1 cyt c at 37 ℃
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for 1h; (f) a mixture of 1 mg mL-1 pristine dextran and 1 mg mL-1 cyt c at 37 ℃ for 1h. GFLC 
conditions: injection volume, 10 μL; column, TSK gel T2000SW; eluent, 20 mM PBS (pH 7.2); 
flow rate, 1.0 mL/min; absorbance detection (Abs), λab=408 nm; FL detection, λexcitation=254 
nm and λemission=370-430 nm.
The protein binding of a series of dextran-related compounds was further evaluated employing 
CYP2E1 spotted on a PVDF membrane. Figure 5a indicates that CL intensity obtained from the 
conjugate of DLB or DL polymer with CYP2E1 was nearly the same. The results confirm that 
biotin and luminol moieties in the polymer had no influence on the interaction with CYP2E1. 
We synthesized pre-DLB polymer having many free aldehyde groups in the framework.  The 
pre-DLB polymer gave only less than half of the CL intensity obtained with the DLB polymer for 
the detection of CYP2E1 (Fig. 5a). In addition, the background signal was increased with the
pre-DLB polymer. Therefore, this pre-DLB polymer was not used for the detection. We thought 
first that there would be aldehyde groups in the DLB polymer left unreacted, since the reaction of
the aldehyde group in the polymer with NH2 group in the protein might result in non-specific 
binding of the polymer to any proteins. However, the DLB polymer definitely showed the 
preference to the particular proteins (Table 1).
We additionally investigated to clarify the mechanism of their interaction. We considered that 
the binding force might be an electrostatic one. We measured the zeta potential of the DLB 
polymer on a Malvern zetasizer. The average zeta potential of the polymer was about -27.32 mV 
(n=3) in the experimental condition of 25 mM Tris buffer at pH 7.2. The pI values of CYP1A2, 
FGF5, CYP2E1, β-NGF, lysozyme, CYP3A4, and cytochrome c were 9.2, 9.4, 8.3, 9.3, 11, 8.3, 
and 9.4, respectively. In the experimental pH region, these proteins should have positive charges. 
The DLB polymer was allowed to react with CYP2E1 in various concentrations of the binding 
buffer, Tris buffer at pH 7.2 (Fig. 5b). Higher concentration of the buffer resulted in lower binding 
ability of the DLB polymer to the protein. Figure 5c shows that pH of the binding buffer affected 
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the interaction between the polymer and the protein. We noticed that the binding between the DLB 
polymer and CYP2E1 is stronger at a neutral pH. Therefore, the binding of the polymer would be 
one of results of an electrostatic interaction between negative charges of the polymer and positive 
charges of the protein. However, as shown in Table 1, some proteins such as luteinizing hormone 
(pI 8.8), adrenocorticotropin hormone (40 residues, pI 8.1), parathyroid hormone (pI 8.1) and 
myoglobin (pI 8.1), did not bind to the polymer, even that they had positive charges at the neutral 
condition. In addition, other proteins such as concanavalin A (pI 5), serum amyloid A (pI 5.9), 
prolactin (pI 6.1), and hemoglobin (pI 6.9) interacted with the polymer, despite they have negative 
charges in the binding buffer. Concanavalin A was a carbohydrate-binding protein, and thus it 
might be absorbed on the polysaccharide groups in the polymer. Although peanut lectin (pI 6.5) 
was also carbohydrate-binding proteins, the protein did not interact with the polymer. Therefore, 
the binding between the polymer and the particular proteins might be caused by not only the 
electrostatic interaction but also another interaction.
Another hypothesis was the steric complementarity that played an important role in the 
interaction between the DLB polymer and the proteins. Since the framework of the polymer has a 
linear long chain structure, its chain having many hydroxyl groups after oxidation and reduction of 
dextran might be able to form a special anchoring site or a binding domain, which led to the 
specific binding of the DLB polymer to the particular proteins. The structural complementarity 
might be the other binding force between the DLB polymer and the proteins.
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Fig. 5. (a) Direct detection of CYP2E1 with a series of dextran-luminol-related compounds. 
CYP2E1 protein (200 ng) spotted on a PVDF membrane, and the membrane was incubated with 
the DLB polymer, DL, pre-DLB polymer or free luminol in 2.0 mL of 25 mM Tris buffer (pH 7.2) 
at 37 ℃ for 30 min. (b) The influence of the concentration of the binding buffer. CYP2E1 protein 
(200 ng) was spotted on a PVDF membrane, and the membrane was incubated with the DLB 
polymer in different concentrations of Tris buffer of pH 7.2 at 37 ℃ for 30 min. (c) The influence 
of pH of the binding buffer. CYP2E1 protein (200 ng) was spotted on a PVDF membrane, and the 
membrane was incubated with the DLB polymer in different pHs of 25 mM Tris buffer at 37 ℃
for 30 min.
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The efficiency of the DLB polymer on the binding to the proteins was investigated by the CL 
detection of different amounts of a protein absorbed onto a PVDF membrane. As shown in Fig. 6, 
the proteins of CYP1A2, CYP2E1 and FGF5 were detected and visualized by the DLB polymer. 
The logarithm of CL intensity was proportional to the amounts of the protein spotted on the 
membrane [y = 0.0131x + 4.0504, r2 = 0.9773 for CYP1A2; y = 0.0142x + 3.8593, r2 = 0.949 for 
FGF5; y = 0.0081x + 4.121, r2 = 0.9366 for CYP2E1; whereas y= ln (CL intensity), x= amount of 
protein (ng) and r2 = correlation coefficient].
Fig. 6. (a) CL imaging and (b) calibration curves of proteins on a PVDF membrane. CYP1A2, 
CYP2E1 and FGF5 (25 –150 ng each) were spotted on a PVDF membrane, and the membrane 
was detected by the DLB polymer.
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The DLB polymer contains numerous biotin moieties which can bind specifically to avidin 
protein. Therefore, after the binding of the polymer to the proteins, the addition of avidin followed 
by further addition of the polymer might lead to the formation of a polymer-avidin assembly, 
which would result in the enlargement of the CL intensity, as shown in Fig. 1. The efficiency of 
the assembly was investigated with different amounts of CYP2E1 spotted on a PVDF membrane 
(Fig. 7). When the membrane spotted with CYP2E1 was treated with avidin and the DLB polymer, 
the CL signal was increased with the increasing amounts of avidin. These results indicate that 
avidin was unambiguously involved in the polymeric polymer assembly. Therefore, the 
enhancement of the CL signal was successfully achieved by the addition of avidin into the 
polymer solution.
Fig. 7. The effect of avidin concentration on the enhancement of CL signal from CYP2E1 bound 
to the DLB polymer. CYP2E1 protein (50, 100 or 200 ng) was spotted on a PVDF membrane. 
After the binding reaction with the DLB polymer, the membrane was additionally incubated with 
avidin (0.01-1 mg mL-1) at 37 ℃ for 10 min in order to form the avidin-DLB polymer assembly.
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The proposed CL-imaging method provided the facile detection for several proteins such as 
CYP1A2, CYP2E1 and CYP3A4 on a PVDF membrane by using the DLB polymer. This polymer 
exhibited sufficient solubility in water, strong CL signal and high ability to bind to avidin. After 
screening various proteins, we found that the CYPs, lysozyme, FGF5, cytochrome c, β-NGF, and 
prolactin strongly bound to the DLB polymer. CL intensity from each protein bound to the 
polymer was logarithmically proportional to the amounts of each protein absorbed onto the 
membrane. By the mediation of avidin, the DLB polymer gave enlarged CL signal. The results in 
this study suggest that the binding ability of the polymer to the proteins was due to its framework, 
and neither luminol nor biotin moieties in the polymer, and might be caused by the comprehensive 
function of both electrostatic and steric complementarities. 
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